Vision

Currently our business focuses on three major areas:

  • Manufacture of generic liposomal medicines employing nPort™ technology;
  • Developing novel formulations to improve PK, efficacy and toxicity profile of drug substances; and
  • Collaborating with pharmaceutical partners to promote nano medicine development.

History

Cureport Inc is a growing pharmaceutical company committed to the development of nano medicines for the treatment of cancer, infection and metabolic diseases. With a strong VC investment, we have established proprietary nanotechnology, nPort™, for drug delivery of small molecules or biologics. nPort™ enables us to quickly establish pipelines of novel nano formulations and generic nano medicines.

Six out of ten insomniacs have stress-related sleep problems and it is very common in cialis pills effects of you can try this out women. A drug called Go Here buy cheap cialis Sildenafil Citrate can help you to find relief from your prolonged erection problems. Characteristics, sturdiness, quality, and usage of generic discount levitra davidfraymusic.coms and products should be taken only with the talk to of a doctor or health reputable. These tablets will only work in response to sexual stimulation. 25mg barato viagra

Management

De-Min Zhu
De-Min ZhuPresident & CEO
Dr. Zhu founded Cureport, Inc. in 2012 and has been serving the company as President and CEO.

Facilities

Boston, MA
Philadelphia, PA
China